Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 31:23:6201-6209.
doi: 10.12659/msm.905451.

Surgical Treatment of Cardiac Tumors: Insights from an 18-Year Single-Center Analysis

Sabreen Mkalaluh  1 , Marcin Szczechowicz  1 , Saeed Torabi  1 , Bastian Schmack  1 , Anton Sabashnikov  2 , Bashar Dib  1 , Matthias Karck  1 , Alexander Weymann  1
Affiliations

Surgical Treatment of Cardiac Tumors: Insights from an 18-Year Single-Center Analysis

Sabreen Mkalaluh et al. Med Sci Monit. .

Abstract

BACKGROUND The aim of this study was to investigate the clinical presentation, operative data, and early and late outcomes of a large patient cohort undergoing surgical treatment for cardiac tumors in our institution. MATERIAL AND METHODS A total of 181 patients underwent surgery because of suspected cardiac tumor in our institution between 1998 and 2016. In 162 cases, the diagnosis was confirmed postoperatively and these patients were included in this study. Preoperative baseline characteristics, operative data, and postoperative early and long-term outcomes were analyzed. RESULTS Mean age at presentation was 56.6±17.6 years, and 95 (58.6%) patients were female. There were 126 (77.8%) patients with benign cardiac tumors, while the remaining patients had malignant tumors (primary and metastasized). The mean follow-up time was 5.2±4.7 years. The most frequent histologically verified tumor type was myxoma (63%, n=102). In terms of malignant tumors, various types of sarcomas presented most primary malignant cardiac tumors (7.4%, n=12). The mean ICU length of stay was 1.7±2.2 days and overall in-hospital mortality was 3.1% (n=5). Frequent postoperative complications included mediastinal bleeding (5.8%, n=9), wound infection (1.3%, n=2), acute renal failure (5.6%, n=9), and major cerebrovascular events (n=7, 4.6%). The overall cumulative survival after cardiac tumor resection was 94% at 30 days, 85% at 1 year, 72% at 5 years, and 59% at 15 years. CONCLUSIONS Surgical treatment of cardiac tumors is a safe and highly effective strategy associated with good early and long-term outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

None.

Figures

Figure 1
Figure 1
A) A 63-year-old patient with angiosarcoma of the main and left pulmonary artery; computed tomography. (B) Rhabdomyosarcoma of the right lung with infiltration of the right pulmonary artery; computed tomography. (C) Left atrial metastasis of skin melanoma in a 56-year-old patient; magnetic resonance imaging. (D) Metastasis of osteosarcoma in the lower lobe of the left lung with infiltration of the left atrium through the left inferior pulmonary vein in a 23-year-old patient; magnetic resonance imaging.
Figure 2
Figure 2
A) Left atrial cardiac myxoma in a 59-year-old patient; transesophageal echocardiography. (B) Aortic valve papillary fibroelastoma in a 53-year-old patient; transesophageal echocardiography. (C) Cardiac myxoma located in the posterior leaflet of the mitral valve in a 64-year-old female patient; computed tomography. (D) The same case (C); transesophageal echocardiography.
Figure 3
Figure 3
Comparison of the cumulative survival based on tumor malignity. Breslow p=0.000, log-rank p=0.000
See this image and copyright information in PMC

References

    1. Elbardissi AW, Dearani JA, Daly RC, et al. Survival after resection of primary cardiac tumors: A 48-year experience. Circulation. 2008;118(14 Suppl):S7–15. - PubMed
    1. Leja MJ, Shah DJ, Reardon MJ. Primary cardiac tumors. Tex Heart Inst J. 2011;38(3):261–62. - PMC - PubMed
    1. Keeling IM, Oberwalder P, Anelli-Monti M, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg. 2002;22(6):971–77. - PubMed
    1. Hudzik B, Miszalski-Jamka K, Glowacki J, et al. Malignant tumors of the heart. Cancer Epidemiol. 2015;39(5):665–72. - PubMed
    1. Ramlawi B, Leja MJ, Abu Saleh WK, et al. Surgical treatment of primary cardiac sarcomas: Review of a single-institution experience. Ann Thorac Surg. 2016;101(2):698–702. - PubMed